STERLING GP (01825) reduced 373 million shares due to a 10-for-1 consolidation.
STERLING GP(01825) announced on March 16, 2026, that the company will reduce 373 million shares due to a "10-for-1" stock consolidation.
STERLING GP (01825) announced on March 16, 2026 that the company will reduce 373 million shares through a "10 to 1" stock consolidation.
Related Articles
Joinn Laboratories (06127): Shareholder Gu Xiaolei and its concerted action person Gu Meifang intend to reduce their A-share holdings.
CHINA EAST AIR(00670): "21 Donghang 01" will be delisted on March 19th ahead of schedule.
Zhejiang Hisun Pharmaceutical (600267.SH): Haibomai atorvastatin calcium tablets received drug clinical trial approval.
Joinn Laboratories (06127): Shareholder Gu Xiaolei and its concerted action person Gu Meifang intend to reduce their A-share holdings.
CHINA EAST AIR(00670): "21 Donghang 01" will be delisted on March 19th ahead of schedule.
Zhejiang Hisun Pharmaceutical (600267.SH): Haibomai atorvastatin calcium tablets received drug clinical trial approval.
